Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Frontiers in Endocrinology|May 7, 2020
Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical CarcinomaRaimunde Liang, Isabel Weigand, Juliane Lippert, et al.
Scientific Reports|March 3, 2017
Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomasIsabel Weigand, Cristina L Ronchi, Marthe Rizk-Rabin, et al.
Clinical Endocrinology|May 8, 2010
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotypeLaura Montefusco, Marcello Filopanti, Cristina L Ronchi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 9, 2009
Evaluation of GH-IGF-I axis in adult patients with coeliac diseaseE Ferrante, C Giavoli, L Elli, et al.
Plos One|August 22, 2014
CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinomaCristina L Ronchi, Silviu Sbiera, Marco Volante, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2012
GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiencyClaudia Giavoli, Eriselda Profka, Elisa Verrua, et al.
Annals of Surgical Oncology|November 17, 2018
Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical TreatmentJoachim Reibetanz, Britta Rinn, Andreas S Kunz, et al.
Endocrine Connections|November 22, 2023
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinomaEmily Warmington, Gabrielle Smith, Vasileios Chortis, et al.
Clinical Endocrinology|June 9, 2007
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal studyC L Ronchi, M Boschetti, E C Degli Uberti, et al.
European Journal of Endocrinology|March 7, 2024
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinomaJuliane Lippert, Gabrielle Smith, Silke Appenzeller, et al.
Pageof 17